Liang, TJ. Hepatitis B: the virus and disease. Hepatology
2009; 49: S13–S21.
Centers for Disease Control and Prevention (CDC). Hepatitis B in: Epidemiology and Prevention of Vaccine-Preventable Diseases, The Pink Book. 13th edn. Atlanta, GA: US Department of Health and Human Services, Public Health Foundation, 2015. Chapter 10. 149–173. (https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepb.pdf). Accessed 5 March 2017.
Lozano, R, et al.
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet
2012; 380: 2095–2128.
Tesher, D, Somekh, E. Hepatitis B vaccines and the immune response to them. Israeli Journal of Pediatrics
Israeli Division of Epidemiology, Public Health Services Ministry of Health. Hepatitis B in: Vaccines Book. Updates: August 2016.
Hartal, M, et al.
Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy. Vaccine
2015; 33: 4878–4885.
Gold, Y, et al.
Decreased immune response to hepatitis B eight years after routine vaccination in Israel. Acta Paediatrica
2003; 92: 1158–1162.
Michaiel, R, et al.
Vertical HBV transmission in Jerusalem in the vaccine era. Harefuah
2012; 151: 671–674, 721, 722.
Joinpoint. Statistical Research and Applications Branch, National Cancer Institute. Joinpoint Regression Program, Version 4.4.0. (http://surveillance.cancer.gov/joinpoint). Accessed 5 January 2017.
Central Bureau of Statistics. Children immunized out of those registered in the mother and infant centers. Table 6.12 Published 10 Septemaber 2015.
Rots, NY, et al.
Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations. Vaccine
2010; 28: 893–900.
El-Asheer, OM, et al.
Immunogenicity of recombinant hepatitis B vaccine among routinely vaccinated healthy and chronically Ill children in Assiut, upper Egypt. Gastroenterology Research
2015; 8: 222–227.
But, DY, et al.
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine
2008; 26: 6587–6591.
Zanetti, AR, et al.
Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet
2005; 366: 1379–1384.
Norouzirad, R, et al.
Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in Ahvaz city southwest of Iran. Hepatitis Monthly
2014; 14: e13625.
El Mazahi, MM, et al.
Long term immunity to hepatitis B vaccine among a sample of secondary school students in Damietta. Journal of American Science
2014; 10: 140–145.
Chinchai, T, et al.
Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunology
2009; 22: 125–130.
Saffar, H, et al.
Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in Iran. Hepatitis Monthly
2014; 14: e17263.
Alfaleh, F, et al.
Long-term protection of hepatitis B vaccine 18 years after vaccination. Journal of Infection
2008; 57: 404–409.
Qawasmi, M, et al.
Age-dependent decrease of anti-HBs titers and effect of booster doses using two different vaccines in Palestinian children vaccinated in early childhood. Human Vaccines & Immunotherapeutics
2015; 11: 1717–1724.
Middleman, AB, et al.
Duration of protection after infant hepatitis B vaccination series. Pediatrics
2014; 133: e1500–e1507.
Spada, E, et al.
Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study. Clinical Microbiology and Infection
2014; 20: O680–O686.
Bagheri-Jamebozorgi, M, et al.
The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Human Vaccines and Immunotherapeutics
2014; 10: 3731–3736.
Chaves, SS, et al.
Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine
2012; 30: 1644–1649.
Lu, CY, et al.
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology
2004; 40: 1415–1420.